Etiology and antibiotic resistance of community-acquired pneumonia

doi:10.3877/cma.j.issn.1674-1358.2018.03.001

Abstract

Abstract:

Community-acquired pneumonia (CAP) is a major cause of adult mortality in Asia. In recent years, despite the continuous advancement in diagnostic technology and the successive listing of new antibiotics, the incidence and mortality of CAP are still relatively high. In different studies, the distribution of pathogenic bacteria in CAP and the drug resistance varies. This article reviews the etiology and drug resistance of community-acquired pneumonia, and provides reference for clinical treatment.

Key words: Aetiology, Antibiotic resistance, Community-acquired, Pneumonia

Yue Hu, Yu Wang, Jingyuan Liu, Fujie Zhang. Etiology and antibiotic resistance of community-acquired pneumonia[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2018, 12(03): 209-211.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsyhlcgrbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-1358.2018.03.001

https://zhsyhlcgrbzz.cma-cmc.com.cn/EN/Y2018/V12/I03/209

References 33

[1]	中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J]. 中华结核和呼吸杂志,2016,39(4):241-242.
[2]	Cillóniz C, Ewig S, Polverino E, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity[J]. Thorax,2011,66(4):340-346.
[3]	Cillóniz C, Ewig S, Polverino E, et al. Community-acquired pneumonia in outpatients: aetiology and outcomes[J]. Eur Respir J,2012,40(4):931-938.
[4]	Cilloniz C, Torres A, Polverino E, et al. Community-acquired lung respiratory infections in HIV-infected patients: microbial aetiology and outcome[J]. Eur Respir J,2014,43(6):1698.
[5]	Almirall J, Boixeda R, Bolíbar I, et al. Differences in the etiology of community-acquired pneumonia according to site of care: a population-based study[J]. Respir Med,2007,101(10):2168-2175.
[6]	Peto L, Nadjm B, Horby P, et al. The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review[J]. Trans R Soc Trop Med Hyg,2014,108(6):326.
[7]	Jain S, Self WH, Wunderink RG, et al. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults[J]. N Engl J Med,2015,373(5):415-427.
[8]	Burk M, El-Kersh K, Saad M, et al. Viral infection in community-acquired pneumonia: a systematic review and meta-analysis[J]. Eur Respir Rev,2016,25(140):178-188.
[9]	邓紫薇, 仇成凤, 李茂作, 等. 成人社区获得性肺炎主要病原体分布的Meta分析[J]. 中国抗生素杂志,2016,41(12):950-955.
[10]	Prina E, Ranzani OT, Polverino E, et al. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia[J]. Ann Am Thorac Soc,2015,12(2):153-160.
[11]	Torres A, Cillóniz C, Ferrer M, et al. Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis[J]. Eur Respir J,2015,45(5):1353.
[12]	Aliberti S, Cilloniz C, Chalmers JD, et al. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective[J]. Thorax,2013,68(11):997-999.
[13]	Jennings LC, Anderson TP, Beynon KA, et al. Incidence and characteristics of viral community-acquired pneumonia in adults[J]. Thorax,2008,63(1):42-48.
[14]	Johansson N, Kalin M, Tiveljung-Lindell A, et al. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods[J]. Clin Infect Dis,2010,50(2):202-209.
[15]	Kumagai S, Ishida T, Tachibana H, Ito A, Ito Y, Hashimoto T. Polybacterial aetiology and outcomes in patients with community-acquired pneumonia[J]. Int J Tuberc Lung Dis,2016,20(1):129.
[16]	刘又宁, 陈民钧, 赵铁梅, 等. 中国城市成人社区获得性肺炎665例病原学多中心调查[J]. 中华结核和呼吸杂志,2006,29(1):3-8.
[17]	Cilloniz C, Ewig S, Gabarrus A, et al. Seasonality of pathogens causing community-acquired pneumonia[J]. Respirology,2017,22(4):778-785.
[18]	Torres A, Blasi F, Peetermans WE, et al. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review[J]. Eur J Clin Microbiol Infect Dis,2014,33(7):1065-1079.
[19]	Braeken DC, Franssen FM, von BH, et al. Bacterial aetiology and mortality in COPD patients with CAP: results from the German Competence Network, CAPNETZ[J]. Int J Tuberc Lung Dis,2017,21(2):236-243.
[20]	聂庆东, 岳志刚, 陈凯. 北京部分地区成年患者社区获得性肺炎的病原学及耐药性分析[J]. 中国实验诊断学,2013,17(3):487-489.
[21]	刘向欣, 尹素凤, 刘运秋. 医院与社区获得性肺炎患者病原菌分布及耐药性分析[J]. 现代预防医学,2013,40(23):4469-4471,4474.
[22]	汪国英, 张曼, 朱贤英, 等. 基层医院社区获得性肺炎人群的病原学分布及耐药性分析[J]. 中国实验诊断学,2015,19(1):81-84.
[23]	卢海跃, 边保华, 葛慷艳. 老年社区获得性肺炎病原菌的分布及耐药性分析[J]. 中国预防医学杂志,2015,16(8):624-627.
[24]	谢宝元, 乜庆荣, 王京. 老年社区获得性肺炎细菌分布及耐药性分析[J]. 中国病案,2016,17(4):58-60.
[25]	陈灵珊, 方莉萍. 肺炎链球菌致老年患者社区获得性肺炎的危险因素与临床耐药性[J]. 中国微生态学杂志,2016,28(4):454-457.
[26]	Yayan J. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae[J]. Drug Des Devel Ther,2014,2014(default):1733-1743.
[27]	尹玉东, 曹彬, 王辉, 等. 北京地区成人社区获得性肺炎患者中肺炎支原体耐药情况的多中心调查[J]. 中华结核和呼吸杂志,2013,36(12):954-958
[28]	孙燕, 孔菁, 张泓, 等. 2005-2014年CHINET流感嗜血杆菌和卡他莫拉菌耐药性监测[J]. 中国感染与化疗杂志,2016,16(2):153-159.
[29]	罗宇鹏. 2014年成都某院流感嗜血杆菌的临床分布及耐药分析[J]. 国际检验医学杂志,2016,37(3):333-335.
[30]	陈世平, 胡慧敏, 冯旰珠, 等. 社区获得性肺炎痰分离菌细菌谱及其耐药性分析[J]. 临床肺科杂志,2015,20(12):2196-2199.
[31]	杨爱兰. 社区获得性肺炎病原学调查及细菌耐药性分析[J]. 河北医药,2013,35(9):1404-1405.
[32]	魏娟娟, 史晓艳. 社区获得性肺炎中肺炎克雷伯菌耐药性及产AmpC酶基因菌株的检测[J]. 贵阳医学院学报,2015,40(9):966-968.
[33]	Rammaert B, Goyet S, Beauté J, et al. Klebsiella pneumoniae related community-acquired acute lower respiratory infections in CAMBODIA: clinical characteristics and treatment[J]. BMC Infect Dis,2011,12(1):3.

Please choose a citation manager

Content to export